Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study

doi:10.5501/wjv.v13.i1.89104

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1384)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

WORD

HTML

710

Figures (1-4)

147

Tables (1-4)

139

Sum=1035

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

210

Sum=306

Mar 25, 2024 (publication date) through Aug 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Virol. Mar 25, 2024; 13(1): 89104
Published online Mar 25, 2024. doi: 10.5501/wjv.v13.i1.89104

Table 4 Baseline hepatitis B virus DNA levels of occult hepatitis B infection group and follow-up at 6 and 12 months after the introduction of prophylaxis (tenofovir or entecavir)

Patient	0 months		6^th months		12^th months
Patient	HBV DNA	Liver enzymes	HBV DNA	Liver enzymes	HBV DNA	Liver enzymes
1	TND	Normal	TND	Normal	TND	Normal
2	TND	Normal	TND	Normal	TND	Normal
3	TND	Normal	TND	Normal	TND	Normal

HBV: Hepatitis B virus; TND: Target not detected.

Citation: Sudevan N, Manrai M, Tilak TVSVGK, Khurana H, Premdeep H. Chronic hepatitis B and occult infection in chemotherapy patients - evaluation in oncology and hemato-oncology settings: The CHOICE study. World J Virol 2024; 13(1): 89104
URL: https://www.wjgnet.com/2220-3249/full/v13/i1/89104.htm
DOI: https://dx.doi.org/10.5501/wjv.v13.i1.89104